PACB — Pacific Biosciences Of California Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Market Cap
$555.51m
Enterprise Value
$902.01m
Revenue
$154.01m

Annual balance sheet for Pacific Biosciences Of California, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,044	772	631	390	280
Net Total Accounts Receivable
Net Total Receivables	24.2	18.8	36.6	27.5	35.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,101	852	742	496	375
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	79.1	81.3	69	46.6	65.8
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	2,007	1,767	1,746	1,260	784
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	71.7	263	95	66.3	133
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,216	1,204	1,045	754	779
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	791	563	701	507	5.35
Total Liabilities & Shareholders' Equity	2,007	1,767	1,746	1,260	784
Total Common Shares Outstanding